Sign in

NCT07611747RecruitingPhase 4

Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)

Randomized Clinical Trial to Assess the Efficacy and Safety of a Primary Prevention Strategy for Cardiovascular Events in Patients With Inflammatory Rheumatic Diseases Based on the Use of Carotid Ultrasound

Source: ClinicalTrials.gov · Last updated 28 May 2026

Brief summary (registry, in English)

PREVENER is a randomized, open-label, multicenter, phase IV clinical trial designed to evaluate the efficacy and safety of a carotid ultrasound-based strategy for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases (IRD). Patients with IRD, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), axial spondyloarthritis (AxSpA), and systemic lupus erythematosus (SLE), have a 50% higher risk of cardiovascular (CV) events compared to the general population. However, conventional CV risk scores (SCORE2/OP) systematically underestimate this risk, leaving many high-risk patients without appropriate preventive treatment. Patients aged ≥50 years with IRD and low-to-moderate CV risk according to SCORE2/OP will be randomized 1:1 to either an experimental group (carotid ultrasound to detect subclinical atherosclerosis) or a control group (standard care according to ESC 2021 guidelines). Patients in the experimental group with carotid plaques will be reclassified as very high CV risk and treated with high-intensity statins (LDL target \<55 mg/dL). The primary endpoint is the incidence of major adverse cardiovascular events (MACE) over 48 months of follow-up.

Status (registry)
Recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
1944 (estimated)
First submitted
14 May 2026
Start date
22 Apr 2026
Primary completion date
22 Apr 2031
Lead sponsor
Instituto de Investigación Marqués de Valdecilla
NCT number
NCT07611747
EU CT number
2025-521086-28-00

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 1944
  • From 22 Apr 2026 to the primary completion date, 22 Apr 2031
  • 17 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Presence of previous cardiovascular events, type 2 diabetes mellitus, familial hypercholesterolemia, or chronic kidney disease resulting in classification as high or very high cardiovascular risk.
  • Prior carotid ultrasound examination with subsequent therapeutic intervention derived from its results, either in the context of a research study or routine clinical practice.

Lab values

  • Contraindications to lipid-lowering therapy, including recent history of alcoholism, active liver disease, or unexplained and persistent elevation of serum transaminases exceeding three times the upper limit of normal (applicable to statins and ezetimibe).

Who the study is looking for

  • Patients aged ≥50 years who have provided written informed consent.
  • Fulfillment of classification criteria for at least one of the following inflammatory rheumatic diseases:
    • Rheumatoid arthritis (RA) according to ACR/EULAR 2010 criteria
    • Psoriatic arthritis (PsA) according to CASPAR criteria
    • Axial spondyloarthritis (AxSpA) according to ASAS criteria
    • Systemic lupus erythematosus (SLE) according to ACR/EULAR 2019 criteria
  • Low-to-moderate cardiovascular risk according to SCORE2/OP classification.

Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (17)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Universitari Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting
Hospital Universitario Basurto
Coordinator of this site? Confirm its status
BilbaoSpainRecruiting
Hospital General Universitario de Ciudad Real
Coordinator of this site? Confirm its status
Ciudad RealSpainRecruiting
Hospital Universitario Reina Sofia
Coordinator of this site? Confirm its status
CórdobaSpainRecruiting
Hospital General Universitario de Elche
Coordinator of this site? Confirm its status
ElcheSpainRecruiting
El Hospital Universitario De Gran Canaria Dr. Negrin
Coordinator of this site? Confirm its status
Las Palmas De Gran CanariaSpainRecruiting
Hospital Universitario Ramón y Cajal
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Hospital Universitario La Paz
Coordinator of this site? Confirm its status
MadridSpainRecruiting
University Clinical Hospital Virgen De La Arrixaca
Coordinator of this site? Confirm its status
MurciaSpainRecruiting
Hospital Vega Baja de Orihuela
Coordinator of this site? Confirm its status
OrihuelaSpainRecruiting
Hospital Son Llatzer
Coordinator of this site? Confirm its status
PalmaSpainRecruiting
Hospital Universitario de Canarias
Coordinator of this site? Confirm its status
San Cristóbal de La LagunaSpainRecruiting
Hospital Universitario Marqués de Valdecilla
Coordinator of this site? Confirm its status
SantanderSpainRecruiting
Hospital Universitario San Juan de Alicante
Coordinator of this site? Confirm its status
Sant Joan d'AlacantSpainRecruiting
Hospital Sierrallana
Coordinator of this site? Confirm its status
TorrelavegaSpainRecruiting
Hospital Universitario Araba
Coordinator of this site? Confirm its status
VitoriaSpainRecruiting
Hospital laredo
Coordinator of this site? Confirm its status
-SpainRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.